| 注册
首页|期刊导航|中国实用内科杂志|进一步规范我国骨髓增殖性肿瘤的诊断和治疗

进一步规范我国骨髓增殖性肿瘤的诊断和治疗

肖志坚

中国实用内科杂志2018,Vol.38Issue(2):89-92,4.
中国实用内科杂志2018,Vol.38Issue(2):89-92,4.DOI:10.19538/j.nk2018020101

进一步规范我国骨髓增殖性肿瘤的诊断和治疗

Standardization of the diagnosis and treatment for MPN in China

肖志坚1

作者信息

  • 1. 中国医学科学院血液学研究所血液病医院,天津300020
  • 折叠

摘要

Abstract

Based on the detection of"driver" JAK2,CALR and MPL gene mutations,the standardization of bone marrow morphologic analysis,and the assessment of symptom burden using MPN-10,it is possible to achieve the most accurate diagnosis of MPN.The diagnostic model of MPN has been moved from clinical-pathology to clinical-pathological-molecular.Nowadays,JAK2 inhibitors treatment may change the natural history of MPN.Some key points for diagnosis and treatment of MPN in China were discussed in this paper.

关键词

骨髓增殖性肿瘤/诊断/治疗

Key words

myeloproliferatic neoplasms/diagnosis/treatment

分类

医药卫生

引用本文复制引用

肖志坚..进一步规范我国骨髓增殖性肿瘤的诊断和治疗[J].中国实用内科杂志,2018,38(2):89-92,4.

基金项目

国家自然科学基金(81530008,81370611,81770129) (81530008,81370611,81770129)

协和学者与创新团队发展计划 ()

天津市科技计划项目(15ZXLCSY00010) (15ZXLCSY00010)

中国实用内科杂志

OACSCDCSTPCD

1005-2194

访问量10
|
下载量0
段落导航相关论文